NCCN Monthly Oncology Tumor Boards: Neoadjuvant and Adjuvant Therapy for Patients with Resectable Early-Stage and Locally Advanced Non-Small Cell Lung Cancer

Course Provider
National Comprehensive Cancer Network
Learning Objectives
Participants will describe the specific targeted therapies and immunotherapies that are currently recommended as neoadjuvant therapy for eligible patients with resected early-stage and locally advanced non-small cell lung cancer (NSCLC).
Participants will describe the specific targeted therapies and immunotherapies that are currently recommended as adjuvant therapy for eligible patients with resected early-stage and locally advanced NSCLC.
Participants will discuss with patients who have resected early-stage and locally advanced NSCLC which type of neoadjuvant/adjuvant therapy is appropriate.